No takes yet. Share an insight, caveat, or question.
Retrospective analysis demonstrates comparable complete response rates in R/R AML with venetoclax addition, suggesting potential benefits for febrile neutropenia.
Ngo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: